Dithiocarbamates enhance tumor necrosis factor-alpha production by rabbit alveolar macrophages, despite inhibition of NF-kappaB.
The tissue-fixed macrophage (Mphi) plays a key role in coordinating the excessive inflammatory response following shock or sepsis. Reactive oxygen intermediates have been recently described as second messengers involved in signal transduction in these cells, including the activation of the transcription factors NF-kappaB and AP-1. The dithiocarbamates are potent antioxidants that inhibit NF-kappaB activation. We postulated that dithiocarbamates would inhibit Mphi activation via inhibition of NF-kappaB. Rabbit alveolar Mphi were obtained by bronchoalveolar lavage and exposed to either pyrrolidine dithiocarbamate (PDTC) or diethyl dithiocarbamate (DDTC) followed by stimulation with LPS (10 ng/mL). Supernatants were analyzed for TNF and prostaglandin E2, (PGE2) and F2-isoprostane (ISP), a marker of membrane lipid peroxidation, production at 18 h. PDTC and DDTC significantly enhanced production of TNF while inhibiting PGE2 and ISP production compared with LPS alone (p < .05). Northern blots revealed increased mRNA for TNF after pretreatment with PDTC, compared with LPS alone. Western blots and oligonucleotide gel shifts of nuclear proteins revealed inhibition of NF-kappaB activation by both PDTC and DDTC. AP-1 activity was shifted to earlier time points by PDTC pretreatment. These results demonstrate transcriptional and functional enhancement of TNF production despite inhibition of NF-kappaB activation. This may be due in part to a loss of autocrine feedback inhibition by PGE2 and enhancement of AP-1 activity. On the basis of these results, we conclude NF-kappaB may be necessary but, in contrast to prior analyzes, is not sufficient for optimal response of the alveolar Mphi to endotoxin.
Bulger
E M
EM
Department of Surgery, University of Washington, Seattle 98195, USA. ebulger@u.washington.edu
Garcia
I
I
Maier
R V
RV
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D015237:Dinoprost / Q000096:biosynthesis; D015232:Dinoprostone / Q000096:biosynthesis; D004050:Ditiocarb / Q000494:pharmacology*; D008070:Lipopolysaccharides / Q000494:pharmacology; D008262:Macrophage Activation / Q000187:drug effects; D016676:Macrophages, Alveolar / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D016328:NF-kappa B / Q000037:antagonists & inhibitors*; D011759:Pyrrolidines / Q000494:pharmacology*; D012333:RNA, Messenger / Q000378:metabolism; D011817:Rabbits; D013859:Thiocarbamates / Q000494:pharmacology*; D018808:Transcription Factor AP-1 / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*
D000975:Antioxidants; D008070:Lipopolysaccharides; D016328:NF-kappa B; D011759:Pyrrolidines; D012333:RNA, Messenger; D013859:Thiocarbamates; D018808:Transcription Factor AP-1; D014409:Tumor Necrosis Factor-alpha; C020972:pyrrolidine dithiocarbamic acid; D004050:Ditiocarb; D015237:Dinoprost; D015232:Dinoprostone